You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Abivax said 50% of patients achieved endoscopic remission at the end of maintenance and plans to file by the end of the year, with one batch submitted 30 days later without changing the review timetable.
Abivax SA reported a €165.9 million net loss for the six months ended June 30, 2026, completed a July 2026 ADS offering generating approximately $874.1 million in net proceeds, and said liquidity would fund operations for at least 12 months.
